Genomics England API 最新情报24

零

The one-day event includes lectures, panel discussions, posters and exhibitions on the diagnosis of rare diseases and cancer, pharmacogenomics (.

New non-executive Director joins Genomics England board... Genomics England is pleased to announce the appointment of Dr Richard Meddings and Dr Doug Gurr.

Revvity Corporation (NYSE: RVTY) today announced the expansion of its partnership with Genomics England, leveraging the expertise and resources of both organizations.

The GEL reference group consisted of 341,922,205 autosomal variants, of which 31,502,703 (9.26%) were insertional deletions. Most of the detected variants are rare: 287.2.

Genomics England has announced the appointment of Dr Rich Scott as Chief Executive Officer (CEO). He will begin as Chief Executive Officer on March 18, 2024.